NDC 0430-0783

ASACOL HD

Mesalamine

ASACOL HD is a Oral Tablet, Delayed Release in the Human Prescription Drug category. It is labeled and distributed by Allergan, Inc.. The primary component is Mesalamine.

Product ID0430-0783_3712f360-d3ac-407d-85bf-48e0d7f298cf
NDC0430-0783
Product TypeHuman Prescription Drug
Proprietary NameASACOL HD
Generic NameMesalamine
Dosage FormTablet, Delayed Release
Route of AdministrationORAL
Marketing Start Date2008-05-28
Marketing End Date2019-03-31
Marketing CategoryNDA /
Application NumberNDA021830
Labeler NameAllergan, Inc.
Substance NameMESALAMINE
Active Ingredient Strength800 mg/1
Pharm ClassesAminosalicylate
NDC Exclude FlagN

Packaging

NDC SPL Data Element Entries

NDC 0430-0783-00 [00430078300]

ASACOL HD TABLET, DELAYED RELEASE
Marketing CategoryNDA
Application NumberNDA021830
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2008-05-28
Marketing End Date2019-03-31

NDC 0430-0783-27 [00430078327]

ASACOL HD TABLET, DELAYED RELEASE
Marketing CategoryNDA
Application NumberNDA021830
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2008-05-28
Marketing End Date2019-03-31

NDC 0430-0783-95 [00430078395]

ASACOL HD TABLET, DELAYED RELEASE
Marketing CategoryNDA
Application NumberNDA021830
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2008-05-28
Marketing End Date2019-03-31

Drug Details

NDC Crossover Matching brand name "ASACOL HD" or generic name "Mesalamine"

NDCBrand NameGeneric Name
0023-5901Asacol HDmesalamine
0430-0783ASACOL HDmesalamine
0023-5853Delzicolmesalamine
0179-0142Lialdamesalamine
0093-5907MesalamineMesalamine
0093-9224mesalaminemesalamine
0378-1375Mesalaminemesalamine
0378-9230Mesalaminemesalamine
0472-1915MesalamineMesalamine
0037-0066Rowasamesalamine
0037-0022sfRowasamesalamine

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.